Personalisation of therapy for people with type 2 diabetes and cardiovascular disease risk
Join Prof. Francesco Giorgino and Dr. Darren McGuire as they discuss personalisation of treatment for patients with both type 2 diabetes and...
Radio and PodcastLive Radio & Podcasts
Health
Diabetes Knowledge into Practice Podcast
A summary of new trial data, guideline recommendations and expert opinion across diabetes care, run by Diabetes Knowledge into Practice ( featuring interviews with leading experts from acros...
Episodes
20 of 23 episodesEffective strategies for encouraging behaviour change
Join Prof. Francesco Giorgino and Dr. Shehla Shaikh as they discuss strategies to help support type 2 diabetes patients during cultural even...
World Diabetes Day – Overcoming Cultural Obstacles to Personalise Diabetes Care
Join Prof. Francesco Giorgino and Dr. Alice Cheng for a discussion on the importance of being culturally sensitive during shared decision-ma...
Congress special: Highlights from EASD 2023
Join Prof. Francesco Giorgino and Dr. Erika Bezerra Parente as they identify some takeaways from EASD 2023, including data and discussions o...
Striving for Balance: Achieving Glycemic, Weight, and Cardiorenal Targets in T2D Care
In this epsisode Prof. Francisco Giorgino & Dr. Vanita Aroda explore how vital it is that we aim to control more than blood glucose levels w...
Highlights from ADA 2023
Join Prof. Francisco Giorgino & Dr. Richard E. Pratley as they discuss their highlights from the 83rd American Diabetes Association (ADA 202...
Conference special: EASD 2022 Highlights | With Prof. Apostolos Tsapas
This year’s EASD was a hybrid event, with delegates able to join either in person in Stockholm, or online via the virtual platform. As usual...
Publication special: Data from the SURPASS program | With Prof Carol Wysham
The SURPASS program of phase 3 clinical trials led to the 2022 FDA approval and positive CHMP opinion of the first GIP/GLP-1 receptor agonis...
Tailoring GLP-1 RA dosing regimens | With Dr Harpreet Bajaj
Heterogeneity across available glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes means that agents should be prescri...
Focus on CKD: Latest guidelines and therapies | With Dr David Cherney
The last two years have provided updated guidelines on management of chronic kidney disease in type 2 diabetes alongside new regulatory appr...
Focus on CVD: How much do we know now? | With Prof. Naveed Sattar
The past year has included the release of new guidelines on cardiovascular disease prevention and further data on cardioprotective agents in...
Advances in incretin therapy: dual agonists and beyond | With Prof. Filip Knop
This year saw the regulatory approval of the first dual GIP/GLP-1 dual agonist for type 2 diabetes. With several other multi-agonists in dev...
Latest approaches to supporting weight loss in T2D | With Dr Robert Kushner
The importance of weight loss in type 2 diabetes was a major topic at the recent American Diabetes Association (ADA) 2022 Scientific Session...
Conference special: ADA 2022 | With Prof. Jennifer Green
The ADA 2022 was full of interesting symposia, updates on ongoing clinical trials, and a draft of an updated ADA-EASD consensus report. This...
NASH: Current and future therapies | With Prof. Philip Newsome
This is a special episode brought to you in association with Hepatology Knowledge into Practice. NASH has historically had very few treatmen...
Publication special: SUSTAIN FORTE | With Dr Juan Pablo Frías
GLP-1 receptor agonists including semaglutide have been shown to offer benefits for glycemic control, weight loss and cardiovascular protect...
Latest data on SGLT2is in heart failure | With Prof. Javed Butler
In late 2020, we published an episode looking at the management of diabetes and heart failure when both present together. Since then, a weal...
Closeup on the ADA 2022 Standards of Medical Care | With Prof. Anne Peters
The 2022 Standards of Medical Care in Diabetes is published every year by the American Diabetes Association to reflect the latest available...
NASH: Advances in non-invasive screening | With Dr Kenneth Cusi
This is a special episode brought to you in association with Hepatology Knowledge into Practice. NASH occurs in around 20% of individuals wi...
Update on Covid-19 and diabetes: What more do we know? | With Prof. Partha Kar
Description: A year ago, we published an episode looking at diabetes management in the context of ongoing restrictions in many parts of the...